This HTML5 document contains 38 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n9http://linked.opendata.cz/resource/drugbank/drug/DB03765/identifier/pdb/
n8http://linked.opendata.cz/resource/drugbank/drug/DB03765/identifier/kegg-compound/
n14http://bio2rdf.org/drugbank:
n11http://linked.opendata.cz/resource/drugbank/drug/DB03765/identifier/pubchem-compound/
admshttp://www.w3.org/ns/adms#
n13http://linked.opendata.cz/resource/drugbank/drug/DB03765/identifier/pubchem-substance/
n6http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
n10http://linked.opendata.cz/resource/drugbank/drug/DB03765/identifier/drugbank/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB03765
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n6:DB03765 n14:DB03765
dcterms:title
Cytidine-2'-Monophosphate
adms:identifier
n8:C03104 n9:C2P n10:DB03765 n11:46936789 n13:46508149
n3:IUPAC-Name
n4:271B4036-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B403C-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B403B-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B4038-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B4039-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B403A-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B4034-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B4035-363D-11E5-9242-09173F13E4C5 n4:271B4032-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B4033-363D-11E5-9242-09173F13E4C5
n3:pKa
n4:271B404C-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B4042-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B4043-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B403D-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B403E-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B4040-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B403F-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B4041-363D-11E5-9242-09173F13E4C5
n3:casRegistryNumber
85-94-9
n3:Bioavailability
n4:271B4048-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B404A-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B404B-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B4047-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B4046-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B4049-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B4037-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B4044-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B4045-363D-11E5-9242-09173F13E4C5